News from NIAID-Supported Institutions
National Institute of Allergy and Infectious Diseases sent this bulletin at 05/28/2013 05:27 PM EDT Here’s your periodic update on News from NIAID-Supported Institutions. The following links will take you to the institution’s press release:
UF Helping Develop Insecticide to Target Malaria-Carrying Mosquitoes
May 23, 2013—University of Florida
Soligenix Announces Issuance of US Patent for its ThermoVax™ Technology
May 22, 2013—Soligenix, Inc.
Vaccine Blackjack: IL-21 Critical to Fight Against Viral Infections
May 22, 2013—Emory Vaccine Center
Penn Study Shows How Immune System Peacefully Co-exists with "Good" Bacteria
May 22, 2013—Perelman School of Medicine, University of Pennsylvania
Mosquito Behavior May Be Immune Response, Not Parasite Manipulation
May 22, 2013—Penn State
Keeping Stem Cells Strong
May 21, 2013—California Institute of Technology
Inflamax Research Selected by the Immune Tolerance Network and the National Institutes of Health to Conduct a Landmark Clinical Study on the Underlying Mechanisms of Allergic Inflammation
May 21, 2013—Inflamax Research
High Fiber Diets May Increase Susceptibility to E. coli Infection
May 21, 2013—Uniformed Services University of the Health Sciences (USU)
Double Trouble: Resistance to Antibiotic Makes Bacteria Resistant to Immune System
May 21, 2013—Emory University School of Medicine
Study Finds Vitamin C Can Kill Drug-Resistant TB
May 21, 2013—Albert Einstein College of Medicine
Sedia Biosciences Announces Global Launch of New Research Assay to Detect Recent HIV-1 Infections
May 20, 2013—Sedia Biosciences Corporation
Part 2 of NIAID-Funded US Clinical Trial of Anti-Staphylococcal Nasal Gel XF-73 Begins Enrollment
May 20, 2013—Destiny Pharma
New Discovery in Fight Against Meningococcal
May 18, 2013—Griffith University
Sorrento Therapeutics, Inc. Announces its Approach to Developing Human Antibody Therapeutics Against MRSA Receives Continued Support from the National Institute of Allergy and Infectious Diseases
May 17, 2013—Sorrento Therapeutics, Inc.
Peer-Referral Programs Can Increase HIV-Testing in Emergency Departments
May 17, 2013—University of Cincinnati
No hay comentarios:
Publicar un comentario